Gentronix, Apredica to Collaborate on Predictive Toxicology | GenomeWeb

NEW YORK (GenomeWeb News) – Gentronix and Apredica said today that they will collaborate on providing drug-discovery support services with a focus on predictive toxicology.

Watertown, Mass.-based Apredica is an ADME-Tox contract research laboratory and has been working with Gentronix on developing "a joint predictive toxicology offering based on a set of assays that accurately predict many known mechanisms of human toxicities," the firm's president, Katya Tsaioun, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.